GlassScriptPhysician profile
William Bollhofer
NPI 1184665929
$3,400.09
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,758 · 2020: $942 · 2021: $47.38 · 2022: $16.97 · 2023: $526 · 2024: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615 · Consulting Fee: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.05 |
| Consulting Fee | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $454.22 | 2019-2023 | Jardiance, Synjardy, Emgality |
| Novo Nordisk INC | $377.80 | 2019-2024 | Rybelsus, Ozempic |
| Allergan, INC. | $306.24 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $281.37 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $260.10 | 2019-2020 | |
| Amgen INC. | $210.56 | 2019-2020 | |
| Pfizer INC. | $209.13 | 2019-2023 | |
| Amarin Pharma, INC. | $157.41 | 2019-2023 | |
| Glaxosmithkline, LLC. | $149.35 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $145.78 | 2019-2020 | |
| Horizon Therapeutics Plc | $134.86 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $111.20 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $109.56 | 2019 | |
| Idorsia Pharmaceuticals US INC | $100.74 | 2023 | Quviviq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.77 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $75.33 | 2020-2024 | Injectafer |
| Takeda Pharmaceuticals U.S.A., INC. | $66.91 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $51.73 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $31.93 | 2019 | |
| Exact Sciences Corporation | $23.25 | 2023 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $23.08 | 2020 | |
| Medtronic USA, INC. | $22.91 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bollhofer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.